

| Package | Price per Dose | Price | |
|---|---|---|---|
| 360 pills | A$0.82 | A$423.84 A$296.69 Free shipping | |
| 270 pills | A$0.95 | A$368.15 A$257.70 | |
| 180 pills | A$1.02 | A$262.96 A$184.07 | |
| 120 pills | A$1.19 | A$204.17 A$142.92 | |
| 90 pills | A$1.39 | A$179.42 A$125.59 | |
| 60 pills | A$1.58 | A$136.10 A$95.27 | |
| 30 pills | A$2.82 | A$120.63 A$84.44 | |
| 20 pills | A$3.90 | A$111.35 A$77.95 | |
| 360 pills | A$1.30 | A$668.26 A$467.78 Free shipping | |
| 270 pills | A$1.41 | A$544.51 A$381.15 Free shipping | |
| 180 pills | A$1.56 | A$402.18 A$281.53 Free shipping | |
| 120 pills | A$1.69 | A$290.80 A$203.56 | |
| 90 pills | A$1.82 | A$235.11 A$164.58 | |
| 60 pills | A$1.99 | A$170.14 A$119.10 | |
| 30 pills | A$2.10 | A$89.69 A$62.79 | |
| 20 pills | A$2.49 | A$71.13 A$49.79 |
Disclaimer: This information is for patient education and does not replace medical advice. Consult a pharmacist or doctor for personal guidance before using Nolvadex (tamoxifen).
Breast cancer is one of the most commonly diagnosed cancers worldwide, underscoring the importance of targeted therapies. Nolvadex is the brand name for tamoxifen, a selective estrogen receptor modulator (SERM) that acts on estrogen receptors in breast tissue. It is used to interfere with the growth of hormone receptor–positive breast cancers by modulating the effect of estrogen in the body. In other tissues, tamoxifen can have different effects compared with breast tissue, which explains some of the broader side effects that may occur.
Tamoxifen binds to estrogen receptors, producing mixed estrogenic and antiestrogenic effects depending on tissue type. In breast tissue, the antiestrogenic action can slow or stop cancer cell growth that depends on estrogen. In other tissues, such as bone or uterus, different actions may occur. In Australia, as with many other health systems, access to Nolvadex typically requires a prescription from a clinician, and the decision to start therapy is based on test results and clinical assessment.
The medicine is available as oral tablets for daily use. The exact dosage and duration of treatment are determined by the prescriber and depend on the cancer type, stage, receptor status, and individual health factors. This information leaflet is intended to support safe and informed use in the Australian context.
In some medical guidelines, tamoxifen may also be considered for breast cancer risk reduction in people at high risk of developing the disease. This use depends on individual risk factors and professional judgement. Consultation with a clinician is recommended to discuss potential benefits and risks.
As with all medicines, a careful balance between potential benefits and possible adverse effects is sought. If any questions arise about the role of Nolvadex in a specific treatment plan, the official patient information leaflet or a clinician should be consulted for clarification.
Tamoxifen is used as part of treatment for certain hormone receptor–positive breast cancers. It is commonly used as adjuvant therapy after surgery or radiation to help reduce the risk of cancer returning. It may be used to treat metastatic breast cancer, in both women and men, when the cancer tests show hormone receptor positivity. In some clinical scenarios, tamoxifen is considered for risk reduction in individuals at high risk of developing breast cancer, subject to professional guidance and local rules.
Prescribing decisions are guided by receptor status, previous treatments, and overall health. The medication is not universally suitable for every breast cancer type, and tests are typically required to determine whether estrogen receptors are present on cancer cells. If testing or treatment goals differ, the clinician may propose alternative therapies.
During therapy, regular medical review is recommended to monitor response and to check for potential adverse effects. If a plan includes Nolvadex, the prescriber will provide tailored instructions regarding what to expect and what to report promptly. In Australia, the need for a prescription is common, and access is coordinated with a healthcare professional.
The information provided here is not a substitute for medical advice. If uncertainties arise about indications, check the official leaflet or consult a healthcare professional for personalised guidance. The treatment plan should reflect current guidelines and individual circumstances.
Another purpose of Nolvadex is to help slow cancer progression when the disease relies on estrogen signalling. This mechanism can contribute to disease control when used in the appropriate clinical setting. Always follow the dosing, monitoring, and safety instructions given by the prescriber.
Starting a new cancer therapy involves several coordinated steps to maximise safety and potential benefit. The following steps outline a general approach, but individual plans may vary. In Australia, a prescription may be required depending on local rules, and access is guided by a clinician.
Before starting, a review of medical history, current medications, and pregnancy status is completed to identify potential interactions and contraindications. Baseline tests or assessments may be advised, including liver function, blood counts, and other evaluations as appropriate.
All instructions from the prescriber and pharmacist should be followed closely. If any information is unclear, consult a healthcare professional for clarification. The goal is to begin therapy safely and effectively while minimising risk.
During the initiation phase, it may be beneficial to document mood, energy levels, and any new symptoms. This information can assist in recognizing early patterns that might require clinical attention. If persistent symptoms arise, contact a clinician promptly.
Access to Nolvadex typically requires a prescription from a doctor or specialist. Depending on local rules, the prescription may be issued by an oncologist, breast cancer specialist, or a general practitioner with experience in cancer care. The medication should be obtained from a reputable pharmacy.
The tablets should be stored in their original container and kept out of direct sunlight. Any questions about authenticity or storage may be addressed with the pharmacist at the point of purchase.
The patient information leaflet accompanying the medicine contains specific instructions about dosage, timing, and potential interactions. If any detail is unclear, seek guidance from the pharmacist or prescriber before starting. Do not modify the prescribed plan without professional advice.
Information about missed doses, dose timing, and what to do in the event of side effects is provided in the leaflet. These details are essential for safe use and effective cancer therapy support.
All medicines currently used should be disclosed to the prescriber and pharmacist, including over-the-counter products and supplements. Certain medicines can interact with tamoxifen and may influence effectiveness or safety. A clinician or pharmacist can identify potential interactions and advise on alternatives or monitoring strategies.
A review of health conditions, such as liver disease, blood clots, or a history of stroke, is important. Some conditions may affect whether Nolvadex is appropriate or require extra precautions during treatment.
A starting plan will be provided by the prescriber, including how long the therapy is expected to continue and how progress will be assessed. Regular follow-up may be arranged to monitor effectiveness and side effects. Any planned laboratory tests or scans should be completed as advised.
Pregnancy status should be reviewed before initiating therapy, as tamoxifen can affect fetal development. If pregnancy is possible during treatment, pregnancy testing and contraception discussions may be recommended in line with clinical guidelines.
Daily administration is the standard approach for tamoxifen therapy, with the specific dose determined by the clinician. The information below provides general guidance to support safe and consistent use. In Australia, the requirement for a prescription depends on local regulations, and dosing is tailored to the individual.
Oral tablets are intended to be swallowed with water. Do not chew, crush, or break the tablet unless specifically instructed by the clinician. Consistency in dosing helps maintain steady levels of the medicine in the body, which is important for treatment effectiveness.
Timing can be important, and some regimens may specify the preferred time of day for taking Nolvadex. Food generally does not affect absorption, but the clinician’s instructions should be followed. If meals influence personal tolerance, the timing can be adjusted accordingly under professional guidance.
If a dose is missed, the recommended action is to take the dose as soon as remembered, unless it is close to the time of the next dose. In that case, the missed dose should be skipped and the regular schedule resumed. Do not double the next dose to make up for a missed one; consult a clinician if there is uncertainty.
The tablets are taken by mouth with plain water. They are usually taken once daily, but the exact schedule depends on the prescribed plan. Adherence is important to maintain the intended therapeutic effect.
Do not alter the dose or stop the medication without discussing it with the prescriber. Sudden discontinuation can affect treatment outcomes and may require medical supervision.
Food intake generally does not require strict timing with Nolvadex, but consistency is recommended. If a pattern of side effects emerges around meals, timing may be adjusted with professional guidance to improve tolerance.
Operational guidance on timing may vary; the prescriber will provide the definite plan for when to take the medicine relative to other therapies or daily activities.
If a dose is forgotten, a dose taken as soon as remembered is appropriate unless it is near the time of the next dose. When close to the next dose, skip the missed dose and resume the regular schedule. Do not take two doses at once to make up for a missed dose.
For any uncertainty about a missed dose, contact a clinician or pharmacist for personalised advice. There is no universal instruction that applies to every patient, since plans are individualized.
Tamoxifen tablets should generally be swallowed whole with water. Splitting, crushing, or chewing is not advised unless explicitly instructed by the prescriber or pharmacist. Altering the physical form can affect how the medicine is absorbed and may increase the risk of side effects.
If vomiting occurs soon after dosing, the clinician will advise on the next steps. In some cases, a repeat dose may be considered, while in others, the regular schedule is resumed as soon as practical. If frequent vomiting develops, contact a healthcare professional for guidance.
Early experiences during treatment vary between individuals. Some symptoms may appear soon after starting therapy, while others emerge after several weeks. A cautious approach to monitoring helps distinguish drug-related effects from other health issues.
Initial responses may include changes in energy levels or mood, which can be influenced by multiple factors. The potential for hot flashes, mild nausea, or vaginal changes is noted, but not every patient experiences these effects. Any persistent symptoms should be discussed with a clinician.
Baseline testing and regular reviews aid in assessing response to therapy and deciding whether any adjustments are necessary. The expected timeline for noticeable effects on cancer control may range over weeks to months, with individual variation expected.
Patients are advised to report any new or worsening symptoms promptly. If signs suggestive of serious conditions occur—such as chest pain, sudden shortness of breath, leg swelling, or severe allergic reactions—seek urgent medical help. The goal is to maintain safety while pursuing potential benefits of treatment.
Consultation with a clinician is advised if any concerning or persistent symptoms develop. The possibility of serious adverse effects, though uncommon, requires timely medical evaluation. Decisions about continuing, adjusting, or stopping therapy should be guided by healthcare professionals.
Specific situations to discuss promptly include severe headaches, visual changes, leg swelling, persistent abdominal discomfort, yellowing of the skin or eyes, or signs of infection. Any unusual vaginal bleeding, pelvic symptoms, or signs of allergy should be reported promptly.
Therapy may interact with other medicines or medical conditions, and ongoing communication with a clinician helps ensure safety. Stopping Nolvadex or changing the approach should only occur under professional supervision and with a clear plan for follow-up care.
For urgent concerns such as chest pain, severe shortness of breath, sudden leg swelling, or signs of a stroke or blood clot, seek urgent medical help. These events require immediate assessment and appropriate management by healthcare professionals.
Nolvadex tablets should be stored at room temperature, away from heat and moisture. The original packaging helps protect the medicine from light and helps maintain quality. Keep out of reach of children and away from pets.
Do not use Nolvadex beyond its expiry date. If there is any doubt about the safety of a tablet, consult the pharmacist. Any leftover medicine should be disposed of according to local guidelines or pharmacist advice, rather than flushed down the toilet or sink.
When travelling, carry the medication in its original packaging with a current prescription or doctor’s letter if required by local rules. This helps ensure proper verification and access to care if needed during travel.
Storage and handling instructions may vary slightly depending on the formulation. Always follow the label and the clinician’s advice to preserve quality and ensure safe use.
A careful assessment of potential risks is performed before starting Nolvadex. Certain conditions may influence whether this medicine is suitable. A clinician may adjust plans based on health status and test results.
Contraindications may include known hypersensitivity to tamoxifen or related compounds, active liver disease, or a history of certain blood clots. The presence of pregnancy or planned pregnancy should be discussed with a clinician, as tamoxifen can affect fetal development.
Interactions with other medicines can occur. Examples include anticoagulants, certain antidepressants, and some hormonal therapies. The prescriber or pharmacist will review current medications to identify potential interactions and provide guidance on monitoring or alternative options.
In case of uncertain interactions or newly started medicines, contact a clinician promptly for advice. If any new medicines are being considered, a pharmacist can help check for potential interactions and adjust plans accordingly.
Travel and daily routines can be managed while taking Nolvadex with proper planning. Keeping a current list of medications, conditions, and emergency contacts is helpful for healthcare visits while away from home. Carry the medicine in its original packaging with any required documents or prescription information.
When visiting a dentist or undergoing procedures, inform the dental team about the current cancer treatment. Some procedures may carry a higher risk of bleeding, and clinicians may adjust care plans accordingly. Maintaining routine health checks is important during therapy.
Practice good skin and sun protection if skin sensitivity is noted during treatment, and report any unusual skin changes or rashes to a clinician. If questions arise about travel logistics or medication management while away from usual care sites, contact a pharmacist for practical guidance.
The following questions address common practical considerations. Answers are cautious and directed at real-world scenarios, without providing universal dosing details. If uncertainty remains, check the official leaflet or consult a healthcare professional.
Notes: In Australia, access to Nolvadex may require a prescription depending on local rules. Always follow local regulatory guidance and professional advice.
May require a prescription depending on local rules. In many settings, medical oversight is needed to ensure appropriate use and safety. Check with a pharmacist or clinician about current requirements in Australia.
Interactions can occur with certain medicines, supplements, or herbal products. A clinician or pharmacist should review all medicines to assess risks and determine whether timing adjustments or monitoring are needed.
Moderation is generally advised, but no strict universal prohibition applies. Liver function and overall health influence safety; discuss personal alcohol use with a clinician if there are concerns.
Tablets are usually intended to be swallowed whole. Crushing or breaking the tablet may alter absorption and safety. Follow the prescriber’s instructions regarding any exceptions.
Store in a cool, dry place away from light, in the original container with the label intact. Carry a copy of the prescription or a physician’s letter if required by local regulations during travel.
Oncologic responses, when present, may take weeks to months and vary between individuals. The timeline depends on cancer type, receptor status, prior therapies, and overall health. Do not expect immediate symptom relief as a reliable measure of benefit.
Take the missed dose as soon as remembered unless it is nearly time for the next dose. If close to the next dose, skip the missed one and resume the regular schedule. Do not double the next dose to compensate for a missed one.
Fertility and menstrual cycles may be influenced in some individuals. Discuss family planning plans with the clinician, as effects can vary and additional guidance may be needed for pregnancy considerations.
Inform the dental team about ongoing treatment. Some procedures may increase bleeding risk or interact with the medicine’s effects. The dentist may adjust care plans or timing accordingly.
Tamoxifen can affect fetal development; contraception or pregnancy management should be discussed with a clinician. If pregnancy occurs or is planned, professional guidance should be sought promptly to determine the best course of action.
Switching should only occur under clinical supervision. The clinician will assess whether a change is appropriate based on cancer characteristics, prior treatments, and tolerability of previous therapies.
Discontinuation decisions should be made with a clinician. Abrupt stopping without guidance can affect treatment outcomes. A plan for tapering or replacement therapy may be needed in some cases.
Dispose of unused tablets according to local guidelines or pharmacist advice. Do not flush medications unless instructed by authorities. A take-back program or pharmacist-led disposal option is preferred where available.
Yes. Inform all healthcare providers, including dentists, about current cancer therapy. This information supports safe care and helps clinicians anticipate potential interactions or bleeding risks during procedures.
New or worsening symptoms should be reported to a clinician promptly. Some signs may require urgent evaluation, particularly those involving chest pain, shortness of breath, leg swelling, severe abdominal pain, or skin reactions.
Not all patients are candidates for tamoxifen. Eligibility depends on cancer receptor status, prior treatments, and overall health. The clinician will determine suitability and discuss alternative therapies if indicated.
Regular follow-up visits are typically planned to monitor response, side effects, and laboratory results. The schedule varies by treatment plan and individual needs. Report any persistent changes or concerns between visits.
14–21 days. Free from A$279.45 .
5–9 days. A$41.92
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
